Molecular properties and pharmacokinetic behavior of cetirizine, a zwitterionic H1-receptor antagonist

被引:122
作者
Pagliara, A
Testa, B [1 ]
Carrupt, PA
Jolliet, P
Morin, C
Morin, D
Urien, S
Tillement, JP
Rihoux, JP
机构
[1] Univ Lausanne, Inst Chim Therapeut, BEP, CH-1015 Lausanne, Switzerland
[2] Univ Paris 12, Fac Med Creteil, Pharmacol Lab, F-94010 Creteil, France
[3] UCB Pharma, B-1420 Braine Alleud, Belgium
关键词
D O I
10.1021/jm9704311
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The ionization and lipophilicity behavior of the antihistamine (H-1-receptor antagonist) cetirizine was investigated, showing the drug to exist almost exclusively as a zwitterion in the pH region 3.5-7.5. In this pH range, its octanol/water lipophilicity is constant and low compared to cationic antihistamines (log D = log P-Z 1.5), whereas its H-bonding capacity is relatively large (Delta log P-Z greater than or equal to 3.1). Conformational, electronic, and lipophilicity potential calculations revealed that zwitterionic cetirizine experiences partial intramolecular charge neutralization in folded conformers of lower polarity. Pharmacokinetic investigations have shown the drug to be highly bound to blood proteins, mainly serum albumin, and to have a low brain uptake, explaining its lack of sedative effects. As such, cetirizine does not differ from "second-generation" antihistamines. In contrast, its very low apparent volume of distribution in humans (0.4 L kg(-1), smaller than that of exchangeable water) implies a low affinity for lean tissues such as the myocardium and is compatible with the absence of cardiotoxicity of the drug. The zwitterionic nature and modest lipophilicity of cetirizine may account for this pharmacokinetic behavior. The suggestion is offered that cetirizine and analogous zwitterions, whose physicochemical, pharmacokinetic, and pharmacodynamic properties differ from those of "first-" and "second-generation" drugs in this class, could be considered as "third-generation" antihistamines.
引用
收藏
页码:853 / 863
页数:11
相关论文
共 56 条
[1]  
Albert A., 1984, DETERMINATION IONIZA
[2]   X-RAY CRYSTAL-STRUCTURE, PARTITIONING BEHAVIOR, AND MOLECULAR MODELING STUDY OF PIRACETAM-TYPE NOOTROPICS - INSIGHTS INTO THE PHARMACOPHORE [J].
ALTOMARE, C ;
CELLAMARE, S ;
CAROTTI, A ;
CASINI, G ;
FERAPPI, M ;
GAVUZZO, E ;
MAZZA, F ;
CARRUPT, PA ;
GAILLARD, P ;
TESTA, B .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (01) :170-179
[3]   New directions in antihistamine research [J].
Aslanian, R ;
Piwinski, JJ .
EXPERT OPINION ON THERAPEUTIC PATENTS, 1997, 7 (03) :201-207
[4]   BJERRUM PLOTS FOR THE DETERMINATION OF SYSTEMATIC CONCENTRATION ERRORS IN TITRATION DATA [J].
AVDEEF, A ;
KEARNEY, DL ;
BROWN, JA ;
CHEMOTTI, AR .
ANALYTICAL CHEMISTRY, 1982, 54 (13) :2322-2326
[5]   PH-METRIC LOG-P .1. DIFFERENCE PLOTS FOR DETERMINING ION-PAIR OCTANOL-WATER PARTITION-COEFFICIENTS OF MULTIPROTIC SUBSTANCES [J].
AVDEEF, A .
QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIPS, 1992, 11 (04) :510-517
[6]   PH-METRIC LOG .3. GLASS-ELECTRODE CALIBRATION IN METHANOL WATER, APPLIED TO PKA DETERMINATION OF WATER-INSOLUBLE SUBSTANCES [J].
AVDEEF, A ;
COMER, JEA ;
THOMSON, SJ .
ANALYTICAL CHEMISTRY, 1993, 65 (01) :42-49
[7]   PH-METRIC LOG-P .2. REFINEMENT OF PARTITION-COEFFICIENTS AND IONIZATION-CONSTANTS OF MULTIPROTIC SUBSTANCES [J].
AVDEEF, A .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1993, 82 (02) :183-190
[8]  
Bickel M.H., 1994, ADV DRUG RES, V25, P55
[9]  
BOUSQUET J, 1996, HISTAMINE H1 RECEPTO, P91
[10]   ACRIVASTINE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACY IN ALLERGIC RHINITIS, URTICARIA AND RELATED DISORDERS [J].
BROGDEN, RN ;
MCTAVISH, D .
DRUGS, 1991, 41 (06) :927-940